STAT Plus: Akebia?s experimental pill meets anemia, heart-safety goals in two late-stage clinical trials

An experimental oral medicine, called vadadustat, could represent a new, more convenient and potentially safer way to treat anemia, a common condition for patients with chronic kidney disease.